BP11093 PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 2.0–3.0 dl/g, Mw: 297–526 kDa

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 2.0–3.0 dl/g, Mw: 297–526 kDa Description

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 2.0–3.0 dl/g, Mw: 297–526 kDa is a thermoplastic polyester featuring reactive carboxyl end groups that enable controlled modification and degradation. Its intrinsic viscosity and molecular weight range indicate predictable flow behaviour and mechanical properties essential for processing in biomedical and advanced material applications. This formulation facilitates integration in systems where modulation of physical properties is critical.

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 2.0–3.0 dl/g, Mw: 297–526 kDa Applications

1.       Healthcare Applications
- Used as a scaffold material in tissue engineering to achieve controlled degradation by leveraging its modifiable carboxyl groups.
- Applied in drug delivery systems to attain precise release profiles through predictable polymer breakdown.

2.       Industrial Applications
- Utilised as an additive in biodegradable packaging to attain environmental decomposition by leveraging its consistent degradation behaviour.
- Serves as a component in specialty coatings to achieve tailored surface interactions by leveraging its reactive end groups.

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 2.0–3.0 dl/g, Mw: 297–526 kDa Packing

The polymer is packaged in moisture-resistant, sealed containers with an inner anti-static lining to minimise contamination. Storage in a cool, dry environment is recommended to preserve material properties and prevent premature degradation. Additional options include vacuum sealing and inert gas packaging. Custom container sizes and labelling are available based on specific order requirements.

Additional Information

PCL (polycaprolactone) is a biodegradable polyester extensively studied in the field of biocompatible materials. Its controlled degradation and ease of processing make it a valuable material for biomedical applications such as tissue scaffolding and drug delivery systems. Understanding the relationship between molecular weight and intrinsic viscosity is critical for tailoring its performance.

The carboxyl termination enhances the polymer's aqueous dispersibility and provides active sites for further chemical modification, thereby improving its compatibility with hydrophilic matrices and facilitating ionic interaction or covalent grafting within composite systems. This expands the material's applicability in advanced manufacturing and functional biomaterial design. Ongoing research continues to refine processing techniques to optimise performance and reliability across diverse applications.

Regulatory Note: This material is intended for industrial and consumer applications. It is the user's responsibility to ensure compliance with all applicable safety and regulatory requirements for its intended use.